Trial Profile
A phase 2 multicenter, double blind, placebo controlled, parallel group study of PF 04447943 in subjects with mild to moderate Alzheimer's disease on stable donepezil therapy
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2012
Price :
$35
*
At a glance
- Drugs PF 4447943 (Primary)
- Indications Alzheimer's disease
- Focus Pharmacogenomic; Therapeutic Use
- 18 Nov 2011 New trial record